OPKO Health CEO and leadership

Phillip Frost is a Board Member at Ym Biosciences Inc., General Partner at Peregrine Ventures Management Ltd, and Board Member at Protalix Ltd and is based in Miami Beach, Florida. He has worked as Governor at American Stock Exchange; Board Member at COCRYSTAL PHARMA, INC.; and Chairman:Dermatology at Mount Sinai. Phillip works or has worked as TRUSTEE at Frost Nevada Investments Trust, BOARD MEMBER at Shanghai Institute for Advanced Immunochemical Studies, and BOARD MEMBER at Smithsonian Institution. He studied at University of Pennsylvania until 1957, Yeshiva University, and Albert Einstein College of Medicine until 1961.

Fuad Fares is a Founder & Chief Technology Officer at OPKO HEALTH, INC. and Professor at University of Haifa and is based in Haifa Haifa, Israel. He has worked as Senior Lecturer at Technion Israel Institute of Technology and head of Molecular Genetics Laboratory at Carmel Medical center. Fuad attended Hebrew University of Jerusalem, Washington University School of Medicine, and Technion Israel Institute of Technology.

Dr. Jane Hsiao H. is a Chief Technology Officer at OPKO HEALTH, INC. and is based in United States.

Mr. Logal has served as OPKO’s Sr. Vice President and Chief Financial Officer since April 2014 and as OPKO’s Vice President of Finance, Chief Accounting Officer and Treasurer since March 2007. From 2002 to 2007, Mr. Logal served in senior management of Nabi Biopharmaceuticals, a publicly traded, biopharmaceutical company engaged in the development and commercialization of proprietary products. Mr. Logal held various positions of increasing responsibility at Nabi Biopharmaceuticals, last serving as Senior Director of Accounting and Reporting. Mr. Logal currently serves on the board of directors of SciVac Therapeutics, Inc. (TSX: VAC), a commercial-stage biopharmaceutical company.

Jane Wood is a Board Member at McDonald Hopkins LLC; Board Member at EMMAUS LIFE SCIENCES, INC.; and Chief Legal & Compliance Ofcr:Bioreference Laboratories at OPKO HEALTH, INC.. She works or has worked as MEMBER at State Bars of New Jersey Massachusetts Ohio & Tennessee. Jane studied at Texas A&M University-Corpus Christi and Vanderbilt University Law School.

Phillip Frost is a Board Member at Ym Biosciences Inc., General Partner at Peregrine Ventures Management Ltd, and Board Member at Protalix Ltd and is based in Miami Beach, Florida. He has worked as Governor at American Stock Exchange; Board Member at COCRYSTAL PHARMA, INC.; and Chairman:Dermatology at Mount Sinai. Phillip works or has worked as TRUSTEE at Frost Nevada Investments Trust, BOARD MEMBER at Shanghai Institute for Advanced Immunochemical Studies, and BOARD MEMBER at Smithsonian Institution. He studied at University of Pennsylvania until 1957, Yeshiva University, and Albert Einstein College of Medicine until 1961.

Fuad Fares is a Founder & Chief Technology Officer at OPKO HEALTH, INC. and Professor at University of Haifa and is based in Haifa Haifa, Israel. He has worked as Senior Lecturer at Technion Israel Institute of Technology and head of Molecular Genetics Laboratory at Carmel Medical center. Fuad attended Hebrew University of Jerusalem, Washington University School of Medicine, and Technion Israel Institute of Technology.

Phillip Frost is a Board Member at Ym Biosciences Inc., General Partner at Peregrine Ventures Management Ltd, and Board Member at Protalix Ltd and is based in Miami Beach, Florida. He has worked as Governor at American Stock Exchange; Board Member at COCRYSTAL PHARMA, INC.; and Chairman:Dermatology at Mount Sinai. Phillip works or has worked as TRUSTEE at Frost Nevada Investments Trust, BOARD MEMBER at Shanghai Institute for Advanced Immunochemical Studies, and BOARD MEMBER at Smithsonian Institution. He studied at University of Pennsylvania until 1957, Yeshiva University, and Albert Einstein College of Medicine until 1961.

Dr. Jane Hsiao H. is a Chief Technology Officer at OPKO HEALTH, INC. and is based in United States.